H.R. 2484

119th CongressReported

Seniors’ Access to Critical Medications Act of 2025

Seniors’ Access to Critical Medications Act of 2025

Sponsored by Diana Harshbarger (Republican-TN-1)

Healthcare Costs & Access Healthcare & Public Health Medicare & Medicaid Pharmaceutical Policy

Cosponsors

26

Actions

5

Roll calls

0

Amendments

0

Related bills

0

Actions

Apr 29, 2025 · House committee actions

Committee Consideration and Mark-up Session Held

Apr 29, 2025 · House committee actions

Ordered to be Reported by the Yeas and Nays: 38 - 7.

Mar 31, 2025 · Library of Congress

Introduced in House

Mar 31, 2025 · Library of Congress

Introduced in House

Mar 31, 2025 · House floor actions

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest activity

Activity

July 2026

Lobbying reported · Mckesson Corporation & Affiliates U.S. Oncology And Rx Savings Solutions (formerly Mckesson Corp) · Jul 20

Mckesson Corporation & Affiliates U.S. Oncology And Rx Savings Solutions (formerly Mckesson Corp) reported 2nd Quarter (Apr 1 - June 30) lobbying for Mckesson Corporation & Affiliates U.S. Oncology And Rx Savings Solutions (formerly Mckesson Corp) — $530,000

BillsH.R. 1 H.R. 2120 H.R. 2444 H.R. 2484 H.R. 3164 H.R. 3514 H.R. 3521 H.R. 4299 S. 257 S. 1816 S. 3822

Lobbying reported · National Association of Chain Drug Stores (NACDS) · Jul 20

National Association of Chain Drug Stores (NACDS) reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association of Chain Drug Stores (NACDS) — $290,000

BillsH.R. 2484 H.R. 2853 H.R. 3164 H.R. 4317 H.R. 4581 H.R. 6400 H.R. 6501 H.R. 6575 H.R. 6609 H.R. 8779 H.R. 8800 S. 526 S. 527 S. 882 S. 927 S. 1404 S. 2426 S. 2626 S. 3345 S. 3788 S. 3822 S. 4106 S. 4509 S. 4784

Lobbying reported · Stanton Park Group · Jul 20

Stanton Park Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Mckesson Corpation And Its Affiliate US Oncology (formerly US Oncology) — $60,000

BillsH.R. 2484 H.R. 4299

Lobbying reported · Avenue Solutions · Jul 20

Avenue Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Large Urology Group Practice Association (lugpa) — $60,000

BillsH.R. 2484 H.R. 4299 H.R. 5582 H.R. 9393 H.R. 9504 S. 2355

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Large Urology Group Practice Association (lugpa) — $90,000

BillsH.R. 2474 H.R. 2484 H.R. 4299 H.R. 8163 H.R. 9504

Lobbying reported · Community Oncology Alliance (COA) · Jul 17

Community Oncology Alliance (COA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Community Oncology Alliance (COA) — $315,500

BillsH.R. 2484 H.R. 4299

Lobbying reported · Association for Clinical Oncology (ASCO) · Jul 16

Association for Clinical Oncology (ASCO) reported 2nd Quarter (Apr 1 - June 30) lobbying for Association for Clinical Oncology (ASCO) — $480,000

Lobbying reported · Powers Pyles Sutter & Verville, P.c. · Jul 14

Powers Pyles Sutter & Verville, P.c. reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association Of Specialty Pharmacy — $120,000

You’re all caught up.